{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:17:20Z","timestamp":1791163040853,"version":"4.1.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.jneuroim.2007.11.002","type":"journal-article","created":{"date-parts":[[2008,2,22]],"date-time":"2008-02-22T11:46:19Z","timestamp":1203680779000},"page":"143-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["High levels of the proNGF peptides LIP1 and LIP2 in the serum and synovial fluid of rheumatoid arthritis patients: Evidence for two new cytokines"],"prefix":"10.1016","volume":"194","author":[{"given":"Eleni","family":"Dicou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2007.11.002_bib1","first-page":"433","article-title":"Nerve growth factor and autoimmune rheumatic diseases","volume":"15","author":"Aloe","year":"1997","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jneuroim.2007.11.002_bib2","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/00001756-199305000-00025","article-title":"Increased levels of NGF in sera of systemic lupus erythematosus patients","volume":"4","author":"Bracci-Laudiero","year":"1993","journal-title":"NeuroReport"},{"key":"10.1016\/j.jneuroim.2007.11.002_bib3","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1053\/j.seminoncol.2006.03.008","article-title":"Paraneoplastic syndromes affecting the nervous system","volume":"33","author":"Darnell","year":"2006","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.jneuroim.2007.11.002_bib4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nrc1782","article-title":"Paradoxical roles of the immune system during cancer development","volume":"6","author":"deVisser","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jneuroim.2007.11.002_bib5","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.bbrc.2006.06.171","article-title":"Multiple biological activities for two peptides derived from the nerve growth factor precursor","volume":"347","author":"Dicou","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4\u20135","key":"10.1016\/j.jneuroim.2007.11.002_bib6","first-page":"211","article-title":"Peptides other than the neurotrophins that can be cleaved from proneurotrophins: a neglected story","volume":"113","author":"Dicou","year":"2007","journal-title":"Arch. Physiol. Biochem."},{"key":"10.1016\/j.jneuroim.2007.11.002_bib7","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0165-5728(97)00008-8","article-title":"Evidence that natural autoantibodies against the nerve growth factor (NGF) may be potential carriers of NGF","volume":"75","author":"Dicou","year":"1997","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2007.11.002_bib8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00001756-199312000-00036","article-title":"Increased frequency of NGF in sera of rheumatoid arthritis and systemic lupus erythematosus patients","volume":"5","author":"Dicou","year":"1993","journal-title":"NeuroReport"},{"key":"10.1016\/j.jneuroim.2007.11.002_bib9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0165-5728(93)90026-U","article-title":"Natural autoantibodies against the nerve growth factor in autoimmune diseases","volume":"47","author":"Dicou","year":"1993","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2007.11.002_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08916939608995352","article-title":"Nerve growth factor (NGF) autoantibodies and NGF in the synovial fluid: implications in spondyloarthropathies","volume":"24","author":"Dicou","year":"1996","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jneuroim.2007.11.002_bib11","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1530\/eje.0.1470371","article-title":"Nerve growth factor and retinoic acid interactions in the control of small cell lung cancer proliferation","volume":"147","author":"Fiorentini","year":"2002","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jneuroim.2007.11.002_bib12","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1023\/A:1022475432077","article-title":"Elevated nerve growth factor levels in the synovial fluid of patients with inflammatory joint disease","volume":"23","author":"Halliday","year":"1998","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jneuroim.2007.11.002_bib13","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1096\/fasebj.8.11.7520879","article-title":"Fibrogenic cytokines and connective tissue production","volume":"8","author":"Kovacs","year":"1994","journal-title":"Faseb J."},{"key":"10.1016\/j.jneuroim.2007.11.002_bib14","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1172\/JCI31537","article-title":"A cytokine-mediated link between innate immunity, inflammation, and cancer","volume":"117","author":"Lin","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2007.11.002_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1469-7580.2003.00203.x","article-title":"Neurotrophins and the immune system","volume":"203","author":"Vega","year":"2003","journal-title":"J. Anat."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572807004213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572807004213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:11:01Z","timestamp":1759047061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572807004213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":15,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0165572807004213"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2007.11.002","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High levels of the proNGF peptides LIP1 and LIP2 in the serum and synovial fluid of rheumatoid arthritis patients: Evidence for two new cytokines","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2007.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}